Browsing Tag
Entresto
1 post
Expanded Entresto Label Makes 1.8 Million More HF Patients Eligible
Expanded labeling for sacubitril/valsartan (Entresto, Novartis) to include adults with chronic heart failure (HF) with left ventricular ejection fraction (LVEF) lower than normal could increase the treatment-eligible population by up to 1.8 million and potentially prevent or postpone as many as 180,000 worsening HF events, according to a new analysis. "If prior implementation barriers to…